Regulation of dihydropyrimidine dehydrogenase in colorectal cancer

Clinical Cancer Research

Volumn 5, Issue 9, 1999, Pages 2566-2570

  Johnston, Stephen J ^a   Ridge, Susan A ^a   Cassidy, James ^a   McLeod, Howard L ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; MESSENGER RNA; THYMINE; URACIL;

ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; MESSENGER RNA SYNTHESIS; PRIORITY JOURNAL; PYRIMIDINE METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; TRANSLATION REGULATION;

COLON; COLORECTAL NEOPLASMS; DIHYDROURACIL DEHYDROGENASE (NADP); GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTESTINAL MUCOSA; LIVER; LIVER NEOPLASMS; OXIDOREDUCTASES; PROTEIN BIOSYNTHESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0032862086     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. 14C by preneoplastic rat liver and rat hepatoma. Cancer Res., 14: 119-134, 1954.
2. Heidelberger, C. Cancer chemotherapy with purine and pyrimidine analogues. Annu. Rev. Pharm., 7: 101-124, 1967.
3. Scrip's. Scrip's Cancer Chemotherapy Report. Scrip's World Pharmaceutical News. 1996.
4. Heggie, G. D., Sommadossi, J. P., Cross, D. S., Huster, W. J., and Diasio, R. B. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile. Cancer Res., 47: 2203-2206, 1987.
5. Etienne, M. C., Lagrange, J. L., Dassonville, O., Fleming, R., Thyss, A., Renee, N., Schneider, M., Demard, F., and Milano, G. Population study of dihydropyrimidine dehydrogenase in cancer patients. J. Clin. Oncol., 12: 2248-2253, 1994.
6. Lu, Z., Zhang, R., and Diasio, R. B. Population characteristics of hepatic dihydropyrimidine dehydrogenase activity, a key metabolic enzyme in 5-fluorouracil chemotherapy. Clin. Pharmacol. Ther., 58: 512-522, 1995.
7. Fleming, R. A., Milano, G. A., Gaspard, M. H., Bargnoux, P. J., Thyss, A., Plagne, R., Renee, N., Schneider, M., and Demard, F. Dihydropyrimidine dehydrogenase activity in cancer patients. Eur. J. Cancer, 29A: 740-744, 1993.
8. Wei, X., McLeod, H. L., McMurrough, J., Gonzalez, F. J., and Fernandez-Salguero, P. Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity. J. Clin. Invest., 98: 610-615, 1996.
9. Etienne, M. C., Cheradame, S., Fischel, J. L., Formento, P., Dassonville, O., Renee, N., Schneider, M., Thyss, A., Demard, F., and Milano, G. Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity. J. Clin. Oncol., 13: 1663-1670, 1995.
10. Yokota, H., Fernandez-Salguero, P., Furuya, H., Lin, K., McBride, O. W., Podschun, B., Schnackerz, K. D., and Gonzalez, F. J. cDNA cloning and chromosome mapping of human dihydropyrimidine dehydrogenase, an enzyme associated with 5-fluorouracil toxicity and congenital thymine uraciluria. J. Biol. Chem., 269: 23192-23196, 1994.
11. Kimura, M., Fujimoto Sakata, S., Matoba, Y., Matsuda, K., Kontani, Y., Kaneko, M., and Tamaki, N. Cloning of rat dihydropyrimidine dehydrogenase and correlation of its mRNA increase in the rat liver with age. J. Nutr. Sci. Vitaminol., 44: 537-546, 1998.
12. McLeod, H. L., Sludden, J., Murray, G. I., Keenan, R. A., Davidson, A. I., Park, K., Koruth, M., and Cassidy, J. Characterisation of dihydropyrimidine dehydrogenase in human colorectal tumours. Br. J. Cancer, 77: 461-465, 1998.
13. Takechi, T., Okabe, H., Fujioka, A., Murakami, Y., and Fukushima, M. Relationship between protein levels and gene expression of dihydropyrimidine dehydrogenase in human tumor cells during growth in culture and in nude mice. Jpn. J. Cancer Res., 89: 1144-1153, 1999.
14. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
15. McMurrough, J., and McLeod, H. L. Analysis of the dihydropyrimidine dehydrogenase polymorphism in a British population. Br. J. Clin. Pharmacol., 41: 425-427, 1996.
16. Jiang, W., Lu, Z., He, Y., and Diasio, R. B. Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma: implication in 5-fluorouracil based chemotherapy. Clin. Cancer Res., 3: 395-299, 1997.
17. Peters, G. J., van Groeningen, C. J., Laurensse, E. J., and Pinedo, H. M. A comparison of 5-fluorouracil metabolism in human colorectal cancer and colon mucosa. Cancer (Phila.), 68: 1903-1909, 1991.
18. Maehara, Y., Moriguchi, S., Emi, Y., Watanabe, A., Kohnoe, S., Tsujitani, S., and Sugimachi, K. Comparison of pyrimidine nucleotide synthetic enzymes involved in 5-fluorouracil metabolism between human adenocarcinomas and squamous cell carcinomas. Cancer (Phila.), 66: 156-161, 1990.
19. Ferninandus, J. A., Morris, H. P., and Weber, G. Behavior of opposing pathways of thymidine utilization in differentiating, regenerating, and neoplastic liver. Cancer Res., 31: 550-556, 1971.
20. Fernadez-Salguero, P., Gonzalez, F. J., Etienne, M. C., Milano, G., and Kimura, S. Correlation between catalytic activity and protein content for the polymorphically expressed dihydropyrimidine dehydrogenase in human lymphocytes. Biochem. Pharmacol., 50: 1015-1020, 1995.
21. Naguib, F. N. M., el Kouni, M. H., and Cha, S. Enzymes of uracil catabolism in normal and neoplastic human tissues. Cancer Res., 45: 5405-5412, 1985.
22. Ho, D. H., Townsend, L., Luna, M. A., and Bodey, G. P. Distribution and inhibition of dihydrouracil dehydrogenase activities in human tissues using 5-fluorouracil as a substrate. Anticancer Res., 6: 781-784, 1986.